This company listing is no longer active
9NE Stock Overview
Solgenics Limited operates as a power supply solutions company in Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Solgenics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0005 |
| 52 Week High | US$0.021 |
| 52 Week Low | US$0.0005 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | -98.12% |
| 5 Year Change | n/a |
| Change since IPO | -99.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9NE | DE Oil and Gas | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.5% | 0.7% |
| 1Y | 0% | 13.5% | 13.8% |
Return vs Industry: 9NE exceeded the German Oil and Gas industry which returned -19.2% over the past year.
Return vs Market: 9NE underperformed the German Market which returned 4.2% over the past year.
Price Volatility
| 9NE volatility | |
|---|---|
| 9NE Average Weekly Movement | 0% |
| Oil and Gas Industry Average Movement | 8.4% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in DE Market | 12.9% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: 9NE has not had significant price volatility in the past 3 months.
Volatility Over Time: 9NE's weekly volatility has decreased from 650% to 0% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 3 | Hanno Pengilly | www.solgenics.com |
Solgenics Limited operates as a power supply solutions company in Africa. The company focuses on the development of a 300MW solar PV plus BESS renewable energy in the Tete Province in northern Mozambique. The company was formerly known as Ncondezi Energy Limited and changed its name to Solgenics Limited in March 2023.
Solgenics Limited Fundamentals Summary
| 9NE fundamental statistics | |
|---|---|
| Market cap | €8.95m |
| Earnings (TTM) | -€2.05m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs 9NE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9NE income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.05m |
| Earnings | -US$2.05m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0036 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 44.1% |
How did 9NE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/06/29 09:48 |
| End of Day Share Price | 2023/06/06 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Solgenics Limited is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alexander Brooks | Canaccord Genuity |
| Martin Potts | Cavendish |
| Andrey Litvin | Edison Investment Research |